Showing 3 of 3 recruiting trials for “pleuropulmonary-blastoma-type-2”
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
RecruitingNCT03382158 ↗
International PPB/DICER1 Registry
RecruitingNCT01247597 ↗
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
👨⚕️ Douglas R Stewart, M.D., National Cancer Institute (NCI)📍 2 sites📅 Started Feb 2011View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →